Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

314 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

NCT00793793

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1220.2.10 Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • 1220.2.15 Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • 1220.2.17 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States
  • 1220.2.11 Boehringer Ingelheim Investigational Site New York, United States
View all 16 locations
View Trial Details
Completed

Gilead Sustained Virologic Response (SVR) Registry

NCT01457755

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham Gastroenterology Associates Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Digestive Health Specialists of the Southeast, PA Dothan, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 325 locations
View Trial Details
Completed

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

NCT01457768

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham Gastroenterology Associates Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Digestive Health Specialists Dothan, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 323 locations
View Trial Details
Completed

PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.

NCT00087633

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • San Francisco, California, United States
View all 28 locations
View Trial Details
Completed

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

NCT03453346

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Chinese PLA 302 Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China
  • Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details

Related conditions